. 2013 Feb 28;12(6):1621–1631. doi: 10.1074/mcp.M112.026427

Table II. Patient demographics.

Male/Female	10:18
Median age	58.4 (30.3–76)
Tumor types
Ovarian/fallopian/peritoneal	7
Melanoma	5
Sarcoma	5
Other^a	11
Median 28 day cycles on therapy	4.75 (0.5–36.5)

Best response
Partial response	5
Stable disease	19
Progressive disease	3
Not evaluable	1

^a Other includes the following: adrenocortical, papillary renal cell, cervical, colon, peritoneal mesothelioma, uterine papillary serous, unknown primary, papillary thyroid, rectal squamous, adenoid cystic breast, and granulosa cell cancers (one each).